Publication date: Jul 07, 2025
We aimed to study the changes in respiratory virus detection rates during the control of the COVID-19 outbreak and to elucidate possible epidemiologic disturbances after the lifting of control measures. Severe acute respiratory infection (SARI) specimens were collected from hospitalized children in Baiyin, China, from 2021 to 2023. We conducted real-time fluorescence quantitative PCR (RT-qPCR) to detect various respiratory viruses, including influenza virus (IFV), human respiratory syncytial virus (HRSV), human rhinovirus (HRV), human parainfluenza virus (HPIV), human metapneumovirus (HMPV), human adenovirus (HADV), enterovirus (EV), and human coronavirus (HCoV). The results were statistically analyzed using SPSS 26. 0 software. A total of 1353 nasopharyngeal swab specimens were collected from children with SARI between 2021 and 2023. The male-to-female ratio of 1. 49:1, the total virus detection rate of 33. 85% (458/1353). Data were analyzed by comparing two distinct periods: before the lifting of the COVID-19 control measures (January 1, 2021 – December 6, 2022) and after the lifting of the control measures (December 7, 2022 – December 31, 2023). During the three-year study period, there was no significant difference in the detection rate of pathogen positivity between the ≤ 1 year (OR: 0. 986, 95% CI: 0. 960-1. 013) and 1-3 years (OR: 1. 018, 95% CI: 0. 997-1. 060) age groups (P > 0. 05). However, there were significant differences in pathogen positivity rates between the 3-6 years (OR: 1. 097, 95% CI: 1. 049-1. 146) and > 6 years (OR: 1. 099, 95% CI: 1. 063-1. 138) age groups (P HRV > HMPV > EV > HCOV > influenza virus (IFV). After the measures were lifted, the order was as follows: EV > IFV > HADV > HCOV > HPIV > HRV > HMPV > HRSV. The peak detection periods for HRV, HMPV, HADV, and EV shifted to later time points compared to those before the measures were lifted. After the lifting of control measures, the positive detection rates of IFV (OR: 1. 090, 95% CI: 1. 059-1. 122), EV (OR: 1. 102, 95% CI: 1. 064-1. 141), HCOV (OR: 1. 043, 95% CI: 1. 017-1. 070), and HADV (OR: 1. 028, 95% CI: 0. 999-1. 059) all significantly increased (P 0. 05); HRSV (OR: 0. 965, 95% CI: 0. 946-0. 985) was significantly reduced (P 0. 05). These findings help clarify that social interventions can influence the prevalence of respiratory viruses in children during unique historical periods. The implementation of COVID-19 control measures may have curbed the spread of respiratory viruses in children during the study period. After the lifting of control measures, monitoring of respiratory pathogens must be strengthened to reduce the harm caused by respiratory viruses to children’s health.
Open Access PDF
| Concepts | Keywords |
|---|---|
| China | Children |
| Fluorescence | Coronavirus disease 2019 |
| Pcr | Respiratory viruses |
| Rhinovirus |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | infection |
| disease | MESH | influenza |
| disease | MESH | parainfluenza |
| disease | IDO | pathogen |
| pathway | REACTOME | Reproduction |
| disease | MESH | Infectious Diseases |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | respiratory infections |
| disease | MESH | morbidity |
| disease | MESH | severe acute respiratory syndrome |
| drug | DRUGBANK | Cysteamine |
| disease | IDO | acute infection |
| disease | IDO | blood |
| disease | MESH | laryngeal edema |
| disease | MESH | chest pain |
| drug | DRUGBANK | Etoperidone |
| disease | IDO | nucleic acid |
| disease | IDO | susceptibility |
| disease | MESH | tics |
| disease | IDO | host |
| disease | MESH | viral infection |